99mTc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 3, 2006, Pages 319-328

  Johnson III, Gerald ^a   Okada, Christine C ^a   Hocherman, Sonia D ^a   Liu, Zhonglin ^b   Hart, Curtis ^c   Khaw, Ban An ^d   Okada, Robert D ^a  

^a UNIVERSITY OF TULSA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^d NORTHEASTERN UNIVERSITY   (United States)

Author keywords

99mTc glucarate; Imaging; Myocardial infarction; Radiotracer kinetics

Indexed keywords

DIAGNOSTIC AGENT; MICROSPHERE; TECHNETIUM 99M; TRACER; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; BLOOD FLOW; BRAIN INFARCTION SIZE; CAMERA; CONTROLLED STUDY; CORONARY REPERFUSION; CORRELATION COEFFICIENT; DOG; DRUG UPTAKE; EPICARDIUM; EUTHANASIA; HEART INFARCTION; IMAGING; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PARAMETER; QUANTITATIVE ANALYSIS; STAINING;

ANIMALS; DOGS; GLUCARIC ACID; METABOLIC CLEARANCE RATE; MYOCARDIAL REPERFUSION INJURY; ORGANOTECHNETIUM COMPOUNDS; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 33644982573     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-1913-x     Document Type: Article

References (12)

1. 99mTc- glucarate. J Nucl Med 2004;45:655-64
2. 99mTc-labeled (bis(N-ethoxy, N-ethyl dithiocarbamato) nitrido technetium (V)) can detect resting ischemia. J Nucl Cardiol 1997;4:217-25
3. 99mTc-glucarate in low flow, hypoxia, and aglycemia. J Nucl Cardiol 2003;10:168-76
4. Narula J, Petrov A, Pak KY, Lister BC, Khaw BA. Very early noninvasive detection of acute experimental nonreperfused myocardial infarction with 99m-Tc-labeled glucarate. Circulation 1997;95:1577-84
5. Khaw BA, DaSilva J, Petrov A, Hartner W. In-111 antimyosin and Tc-99m glucaric acid for noninvasive identification of oncotic and apoptotic myocardial necrosis. J Nucl Cardiol 2002;9:471-81
6. Khaw BA, Atsuko N, O'Donnell SM, Pak KY, Narula J. Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment. J Nucl Cardiol 1997;4:283-90
7. Yaoita H, Fischman AJ, Wilkinson R, Khaw BA, Juweid M, Strauss HW. Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium. J Nucl Med 1993;34:1303-8
8. Ohtani H, Callahan RJ, Khaw BA, Fishman AJ, Wilkinson RA, Strauss HW. Comparison of technetium-99m-glucarate and thallium-201 for the identification of acute myocardial infarction in rats. J Nucl Med 1992;33:1988-93
9. Beanlands RSB, Ruddy TD, Bielawski L, Johansen H. Differentiation of myocardial ischemia and necrosis by technetium-99m-glucaric acid kinetics. J Nucl Cardiol 1997;4:274-82
10. Johnson LL, Schofield L, Mastrofrancesco P, Donahay T, Farb A, Khaw BA. Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand. J Nucl Cardiol 2000;7:590-8
11. Orlandi C, Crane PD, Edwards DS, Platts SH, Bernard L, Lazewatsky J, et al. Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid. J Nucl Med 1991;32:263-8
12. 99mTc-labeled D-glucaric acid imaging in patients with acute chest pain. J Nucl Med 1999;40:1832-9